For Immediate Release
EDITOR'S NOTE: Photos of event available upon request
BOSTON CURE PROJECT EVENT RAISES AWARENESS AND DONATIONS TO MOVE CLOSER TO A CURE FOR MULTIPLE SCLEROSIS
Event Hints at Key Scientific Benefits of Upcoming Blood, Tissue, and Data Bank
Waltham, MA—November 27, 2002—The Boston Cure Project for Multiple Sclerosis raised additional awareness of Multiple Sclerosis (MS), its genetic and environmental factors, and its often devastating effects to an audience of 250 people at its Second Annual Event held recently at the MIT Faculty Club. The Boston Cure Project raised over $20,000 from sponsors and individual donations to support the event and help researchers uncover the causes of MS that lead to a cure. Several high-powered local clinicians and researchers from Harvard and neighboring hospitals were on hand to present and support the question and answer process.
Mr. Art Mellor, Boston Cure Project CEO and co-founder said, "By raising awareness of how Boston Cure Project is synthesizing MS information generated by individual scientists,; we can create more of a collaborative effort to find the causes we believe will lead to a cure."
Dr. Timothy Vartanian, co-founder of Boston Cure Project and Chief Scientist, as well as the Chief of the Division on Demyelinating Diseases at Beth Israel, and an associate professor of neurology at Harvard University, gave details of the Boston Cure Project's soon to be unveiled Blood, Tissue, and Data Bank. The Data Bank will serve as a vital tool for future research on the disease.
Dr. Vartanian said, "The Blood, Tissue and Data Bank, which will be officially unveiled in early 2003, is designed to collect information , as well as blood and tissue samples from people with MS and appropriate control subjects - a resource not generally available through individual scientific studies."
Dr. Peter Lansbury, Boston Cure Project member of the scientific advisory board and Director at the Center for Neurologic Diseases at Brigham and Young Women's Hospital, discusssed high- throughput drug discovery methods and how they might be applied to MS to develop treatments once the causes are known.
This Multiple Sclerosis event was not without humor. It featured a comic act from guest speaker Jonathan Katz, the accomplished standup comic, musician, actor, and writer who is especially well-known as the co-creator and star of Comedy Central's animated hit series "Dr. Katz: Professional Therapist". Jonathan concluded his act by beaming, via a personal digital assistant, an earlier monologue he'd given on David Letterman to Art Mellor. Art proceeded to read the monologue from the PDA. The overall consensus was that Art wasn't "all that bad, but he should stick to finding the causes of MS that lead to a cure!"
About The Boston Cure Project
The Boston Cure Project for Multiple Sclerosis, www.bostoncure.org, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its causes. Boston Cure Project believes this effort can be accelerated by organizing the research process and encouraging collaboration between research organizations and clinicians. A "Cure Map" is currently being developed by the Boston Cure Project to establish what is known and what is not known about the causes of MS. From the Cure Map, Boston Cure Project will facilitate research most likely to reveal the causes of MS in the shortest time through a large-scale, multidisciplinary, MS Repository. For more information about the Boston Cure Project or to make a corporate or individual donation, call 781/487-0008, visit bostoncure.org, or send an email to email@example.com.
About Multiple Sclerosis
Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue and other serious symptoms. MS affects over 400,000 people in the US and 2 million individuals worldwide. The disorder occurs twice as often in women as in men. The cause is not known and there is no known cure.